So-Young International Q4 25 Earnings Conference Call At 7:30 AM ET

So-Young International will host a conference call at 7:30 AM ET on March 25, 2026 to discuss Q4 2025 earnings; a live webcast (https://ir.soyoung.com) and dial-in numbers are provided with passcodes for live and replay access. This release is a routine investor-relations notice and contains no financial results or guidance.

Analysis

The immediate market event is binary: management commentary on user growth, ARPU/take-rate trends and clinic monetization will drive a high-probability intraday move. Expect realized move in SY to be 8–18% on the print and another 5–12% in the following 1–5 trading days as headlines on guidance flow; the directional implication hinges more on ARPU/take-rate acceleration than top-line beats. Track three metrics in the script and slides: paying user retention (sequential change), non-advertising revenue share (services vs traffic), and clinic churn — each has outsized leverage to near-term margins.

Second-order competitive effects matter: a sustained uptick in platform take-rates will force smaller clinics to absorb margin compression or raise prices, shifting volume to integrated players (e.g., large local service aggregators) over 6–12 months. Conversely, evidence of improved clinic unit economics could accelerate device/consumables purchases upstream, offering a lead indicator for medical-device suppliers in China. Also consider liquidity/float: low free float will amplify moves and create short-squeeze risk on any surprise guidance changes.

Primary tail risks that could reverse a positive read are regulatory headlines on medical aesthetics or a single high-profile malpractice incident; these have historically produced multi-week drawdowns (>30%) for peers. Time horizon segmentation matters: treat the next 3 trading days as event-driven volatility; 3–12 months as a fundamentals re-rate window where user monetization and competitive positioning decide the direction. Nasdaq (NDAQ) sees immaterial direct impact beyond transient options/market-data volumes but benefits slightly from higher event-driven activity on the listing.

Key Decisions for Investors

• Event-volatility: If SY options are liquid, buy an at-the-money 30-day straddle 2–3 days before the call to capture implied-vol mispricing; target realized move >15% for a 1.5–2x payoff, max loss = premium. If options are illiquid, buy shares sized to 1–2% of portfolio with a mental stop at -10% and trim into strength (+20–40%).
• Post-print dip entry: If SY gaps down >15% on conservative guidance or regulatory noise, initiate a tactical long with a 6–12 month horizon — position size 2–4% of portfolio, stop-loss 10%, upside target 40% if ARPU/take-rate recovery is confirmed within two quarters.
• Risk-off hedge: If long exposure to Chinese discretionary/beauty names, hedge with a short position in a China consumer ETF (e.g., KWEB) sized to offset 30–50% of the SY position’s beta to Chinese consumer sentiment for 1–3 months around the call.
• Avoid asymmetric short into print: do not short SY into the call due to low float/short-squeeze risk and binary guidance surprises; consider shorting only after clear multi-quarter deterioration in user KPIs and a confirmed downtrend over 2–3 earnings cycles.